Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma

Figure 4

Validation of the relationship between the GILncSig and the prognosis. (a–c) The time-dependent ROC of GILncSig and other clinicopathological features. (d, e) The distribution of the risk score and survival time. The dashed line presents the cutoff value, which divides HCC patients into the low-risk and high-risk groups. Patients’ survival time decreased as the GILncSig score increased. (f, g) The GILncSig is an independent prognostic predictor in HCC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)